Advanz Pharma Services (India) Private Limited

Advanz Pharma Services (India) Private Limited - business outsourcing in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74990MH1999FTC120396 Incorporated 18 June 1999 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Foreign Private Limited Company business outsourcing
Data last updated
Revenue · FY 2025
₹184.77 Cr
▲ 14% YoY
Net profit · FY 2025
₹21.8 Cr
Net margin 11.8%
EBITDA · FY 2025
₹36.9 Cr
EBITDA margin 20%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Company age
27 yrs
Est. 1999
Employees · EPFO
336
Provident fund records
Directors on board
3
As per MCA filings

About Advanz Pharma Services (India) Private Limited

Data last updated:

Advanz Pharma Services (India) Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Mercury Pharma International Limited. It operates in the business process outsourcing sector. It was incorporated on 18 June 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74990MH1999FTC120396. Its GSTIN is 27AABCG5694A1ZP (Maharashtra). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Concordia International (India) Private Limited and Mercury Pharma Services Private Limited. It is led by directors including Bhavesh Harji Godhania and Gaurav Wadhwa.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Level – 5 – Tower II Phase II Raiaskaran Tech Park Andheri Kurla Road Andheri (East), Mumbai, Maharashtra, India – 400072.

As per the financials filed for FY 2025, the company reported a revenue of ₹184.77 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹21.8 Cr (net margin 11.8%) and EBITDA of ₹36.9 Cr (EBITDA margin 20%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.

The company has about 336 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Concordia International. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending. The company has 2 deals on record (2 secondary share transfers); the latest was in March 2022. The company has 2 MSME Form 1 returns on record for the period ending Sep 2022, listing 2 overdue payments to 1 micro and small supplier.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website concordiarxinternational.com.

Company details

CIN U74990MH1999FTC120396
Registration Number 120396
Incorporation Date 18 June 1999
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Mercury Pharma International Limited
Compliance Status Active Compliant

Name history

Advanz Pharma Services (India) has undergone 7 name changes throughout its history. The current legal name is Advanz Pharma Services (India) Private Limited.

Company NameStatus
Advanz Pharma Services (India) Private LimitedCurrent
Concordia International (India) Private LimitedPrevious
Mercury Pharma Services Private LimitedPrevious
Concordia International (India) Servicesprivate LimitedPrevious
Amdipharm Mercury Services Private LimitedPrevious
Concordia International (India) Services Private LimitedPrevious
Goldshield Services Private LimitedPrevious
Concordia International Rx (India) Private LimitedPrevious

CIN history

Advanz Pharma Services (India) has one previous CIN (Corporate Identification Number): U74990MH1999PTC120396. The current CIN is U74990MH1999FTC120396, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74990MH1999FTC120396Current
U74990MH1999PTC120396Previous

Contact details

Advanz Pharma Services (India) Private Limited's registered office is in Mumbai, Maharashtra. Its website is concordiarxinternational.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Level – 5 – Tower II Phase II Raiaskaran Tech Park Andheri Kurla Road Andheri (East), Mumbai, Maharashtra, India – 400072
  • Industry
    Business Outsourcing, Business Process Outsourcing

To see the full contact details of Advanz Pharma Services (India) Private Limited, buy the company report.

Comprehensive company report
Advanz Pharma Services (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Advanz Pharma Services (India) operates one associated brand: Concordia International. Each brand links to its own profile.

BrandDescriptionWebsite
Distributes specialty pharmaceutical drugs to healthcare providers.concordiarxinternational.com

Business activity

The main business activity of Advanz Pharma Services (India) is support service to organizations. In detail, this covers other support services to organizations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NSupport service to OrganizationsN7Other support services to organizations

To see the full business activity and turnover split of Advanz Pharma Services (India) Private Limited, buy the company report.

Financials of Advanz Pharma Services (India) Private Limited

FY 2025 filings available

Advanz Pharma Services (India) Private Limited reported revenue of ₹184.77 Cr (up 14% YoY) for FY 2025.

Revenue · FY 2025
₹184.77 Cr ▲ 14%
Net profit · FY 2025
₹21.8 Cr margin 11.8%
EBITDA · FY 2025
₹36.9 Cr margin 20%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 18%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 21%
5 years · compounded
▲ 10%

Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 14% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹36.9 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹21.8 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin20%
Net Profit Margin11.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Advanz Pharma Services (India) Private Limited, buy the company report.

Board of directors of Advanz Pharma Services (India) Private Limited

Advanz Pharma Services (India) has 3 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhavesh Harji GodhaniaDirector30 Sep 201313 Years 1 MonthsCurrent
Gaurav WadhwaDirector22 Mar 20224 Years 7 MonthsCurrent
Abhishek SinhaDirector23 Feb 20224 Years 8 MonthsCurrent

Auditor

Advanz Pharma Services (India) Private Limited is audited by Price Waterhouse & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Price Waterhouse & Co.FY 2023FRN304026E/E-300009

Shareholding

The shareholding of Advanz Pharma Services (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Advanz Pharma Services (India) Private Limited, buy the company report.

Deals & funding

Advanz Pharma Services (India) Private Limited has 2 deals on record (2 secondary share transfers); the latest was in March 2022.

Total deals
2
Secondary share transfers
2

Deals on record (2 of 2)

WhenDealAmountParties
Mar 2022Secondary share transferUndisclosedBuyer: Mercury Pharma International Limited, Mercury Pharma Group Limited
Seller: Goldshield Healthcare Private Limited
Feb 2007Secondary share transferUndisclosedBuyer: Goldshield Healthcare Private Limited
Seller: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Advanz Pharma Services (India) Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2022, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
Techsol Life Sciences Private Limited

To see the full MSME payment records of Advanz Pharma Services (India) Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Advanz Pharma Services (India) Private Limited has a workforce of 336 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
336
Active EPFO establishments
1
Employee growth
5%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27336
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Advanz Pharma Services (India) Private Limited, buy the company report.

GST

Advanz Pharma Services (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AABCG5694A1ZPMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Advanz Pharma Services (India) Private Limited, buy the company report.

Recent activity

Advanz Pharma Services (India) Private Limited has 21 board changes on record since 2007: 3 appointments and 18 cessations. The latest: Abhishek Sinha ceased to be Additional Director on 30 Sep 2022.

AGM
Advanz Pharma Services (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Advanz Pharma Services (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Abhishek Sinha ceased to be Additional Director.
Ceased
Andreas Stickler ceased to be Additional Director.
Ceased
Gaurav Wadhwa ceased to be Additional Director.
Appointed
Gaurav Wadhwa was appointed as Director.
Appointed
Abhishek Sinha was appointed as Director.
Ceased
Pavan Satish Chullani ceased to be Additional Director.
Ceased
Pooja Subhash Minocha ceased to be Whole-Time Director.
Ceased
Gurusubramanian Gopalan ceased to be Whole-Time Director.
Ceased
Graeme Neville Duncan ceased to be Additional Director.
Ceased
Pradip Kumar Mukherjee ceased to be Managing Director.

12 earlier events are in the company report.

Frequently asked questions

Advanz Pharma Services (India) is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in business process outsourcing, within the business outsourcing industry. It was incorporated on 18 June 1999 (27+ years old) and is registered under CIN U74990MH1999FTC120396.

Advanz Pharma Services (India) has 3 current directors:

The latest financial statements of Advanz Pharma Services (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Advanz Pharma Services (India) is 27AABCG5694A1ZP, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Advanz Pharma Services (India) is U74990MH1999FTC120396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Advanz Pharma Services (India) has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.

Advanz Pharma Services (India) was incorporated on 18 June 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.

Advanz Pharma Services (India) has 2 deals on record (2 secondary share transfers); the latest was in March 2022.

Abhishek Sinha ceased to be Additional Director on 30 Sep 2022. Andreas Stickler ceased to be Additional Director on 30 Sep 2022. Gaurav Wadhwa ceased to be Additional Director on 30 Sep 2022. Advanz Pharma Services (India) has 21 board changes on record in total.

Advanz Pharma Services (India) has 2 MSME Form 1 returns on record for the period ending Sep 2022, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 08 Feb 2024.

Advanz Pharma Services (India) can be reached through the website concordiarxinternational.com. Its registered office is in Mumbai, Maharashtra, India.